-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
Ambrx Biopharma, Inc. quarterly Assets, Current history and growth rate from Q4 2022 to Q3 2023.
- Ambrx Biopharma, Inc. Assets, Current for the quarter ending September 30, 2023 was $234M.